Characterization of the NS5 Methyltransferase Domain of Dengue Virus Serotype 4: Structural, Functional, and Post-Translational Insights

Background

The NS5 Methyltransferase (MTase) domain of Dengue Virus Serotype 4 (DENV-4) plays a central role in viral RNA capping, genome replication, and immune evasion. Understanding its structural and functional properties is essential for antiviral drug development.

Purpose

This study aimed to characterize the structural features, functional motifs, and potential post-translational regulation of the NS5 MTase domain using computational approaches.

Materials and Methods

Bioinformatic analyses were conducted to examine the genomic organization and amino acid sequence of the NS5 MTase domain. Secondary structure prediction determined α-helix and β-strand composition. Sequence logo analysis identified conserved catalytic motifs. ProtScale analysis evaluated physicochemical property variations. Potential O-glycosylation and phosphorylation sites were predicted, along with nucleotide-binding residues. Distance constraint modeling was used to assess the Three-Dimensional (3D) structural organization.

Results

The NS5 MTase domain consists of 263 amino acid residues, with approximately 30% forming α-helices and 16% forming β-strands. Flexible terminal regions may facilitate conformational adaptation during catalysis. Conserved catalytic motifs were identified, highlighting residues essential for methyl donor binding and enzymatic activity. ProtScale analysis revealed alternating hydrophobic and functional regions contributing to structural stability. Predicted O-glycosylation and phosphorylation sites, along with ATP-, AMP-, and GTP-binding residues, suggest possible post-translational regulatory mechanisms. Distance constraint modeling demonstrated a compact 3D structure with cooperative interactions among catalytic residues.

Conclusion

This study provides a comprehensive bioinformatic characterization of the NS5 MTase domain of DENV-4, offering structural and functional insights that may support the rational design of antiviral agents targeting dengue virus replication.